Novo Nordisk A/S (OTC Pink - Current Information:NONOF)

49.11
Delayed Data
As of 3:20pm ET
 +0.15 / +0.31%
Today’s Change
40.99
Today|||52-Week Range
54.25
+8.43%
Year-to-Date
Seattle Genetics' Adcetris Gets EC Nod for Label Expansion
Feb 12 / Zacks.com - Paid Partner Content
Sanofi's Myeloma Candidate Meets Goal in Phase III Study
Feb 05 / Zacks.com - Paid Partner Content
Sanofi (SNY) Q4 Earnings Top, Genzyme Unit Drives Sales Growth
Feb 07 / Zacks.com - Paid Partner Content
Merck's Keytruda Clinches CHMP Nod for Difficult Lung Cancer
Feb 05 / Zacks.com - Paid Partner Content
Novo Nordisk Is on the Upswing -- for Now
Feb 05 / MotleyFool.com - Paid Partner Content
Novo Nordisk (NVO) Q4 2018 Earnings Conference Call Transcript
Feb 02 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close48.96
Today’s open50.00
Day’s range49.11 - 50.00
Volume35,843
Average volume (3 months)45,266
Market cap$93.3B
Data as of 3:20pm ET, 02/15/2019

Growth & Valuation

Earnings growth (last year)-1.16%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+4.51%
P/E ratio35.3
Price/Sales--
Price/Book--

Competitors

No competitors data available.

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$17.7B
Annual profit (last year)$6.1B
Net profit margin34.54%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
President &
Chief Executive Officer
Lars Fruergaard Jørgensen
Executive Vice President-
International Operations
Maziar Mike Doustdar
Corporate headquarters
Bagsværd, Capital Region

Forecasts